Epilepsy affects millions, with 1/3 unresponsive to meds. CIRM funds early- to clinical-stage research for new stem cell therapies at UCSF & Neurona Therapeutics, offering hope for a better life. Learn more: https://bit.ly/3LWmYZz

CIRM’s 2025 Annual Report, Looking Forward: Advancing California’s Scientific Vision, is now available. It highlights #ScientificProgress, patient stories, and efforts to expand access to #RegenerativeMedicine across California.

Explore it here: https://adobe.ly/42FSVed

Thank you to all the incredible trainees, program directors, patient advocates, and inspiring speakers who joined us for the 2025 #CIRMTraineeConference!

We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech

Millions live with painful osteoarthritis worldwide. A CIRM-funded clinical trial by Genascence reported positive early results using a gene therapy approach, demonstrating safety and sustained efficacy at 12 months.

Learn more on our blog at bit.ly/4nzlpzb

#BlueskyBiotech #Science #ClinicalTrials

Backed by a $14 million CIRM award, Neurona Therapeutics is advancing a stem cell therapy that could transform epilepsy treatment without surgery or tissue damage. Learn more on our blog: blog.cirm.ca.gov/2025/06/20/n...

#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine

CIRM is officially on BlueSky 🦋

The California Institute for Regenerative Medicine (CIRM) is expanding its reach to BlueSky to share the latest developments in California stem cell and gene therapy research initiatives. [1/3]